vl3 Search Results


pvrc8400 xbb s 2p plasmid  (Addgene inc)
93
Addgene inc pvrc8400 xbb s 2p plasmid
Pvrc8400 Xbb S 2p Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pvrc8400 xbb s 2p plasmid/product/Addgene inc
Average 93 stars, based on 1 article reviews
pvrc8400 xbb s 2p plasmid - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
rectal thermistor rec-u-vl3-0  (Grant Instruments)
90
Grant Instruments rectal thermistor rec-u-vl3-0
Rectal Thermistor Rec U Vl3 0, supplied by Grant Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rectal thermistor rec-u-vl3-0/product/Grant Instruments
Average 90 stars, based on 1 article reviews
rectal thermistor rec-u-vl3-0 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
peu vl 3.2  (Cambridge Antibody Technology Group)
90
Cambridge Antibody Technology Group peu vl 3.2
Peu Vl 3.2, supplied by Cambridge Antibody Technology Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peu vl 3.2/product/Cambridge Antibody Technology Group
Average 90 stars, based on 1 article reviews
peu vl 3.2 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
selected yeast vl3  (Lallemand inc)
90
Lallemand inc selected yeast vl3
Selected Yeast Vl3, supplied by Lallemand inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/selected yeast vl3/product/Lallemand inc
Average 90 stars, based on 1 article reviews
selected yeast vl3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
6fr vl3.5 guide catheter  (Boston Scientific Corporation)
90
Boston Scientific Corporation 6fr vl3.5 guide catheter
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
6fr Vl3.5 Guide Catheter, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/6fr vl3.5 guide catheter/product/Boston Scientific Corporation
Average 90 stars, based on 1 article reviews
6fr vl3.5 guide catheter - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vl 3′-terminal extension primer pvlex  (PrimerDesign Inc)
90
PrimerDesign Inc vl 3′-terminal extension primer pvlex
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Vl 3′ Terminal Extension Primer Pvlex, supplied by PrimerDesign Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vl 3′-terminal extension primer pvlex/product/PrimerDesign Inc
Average 90 stars, based on 1 article reviews
vl 3′-terminal extension primer pvlex - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
plasma vl >3 logs  (Abbott Laboratories)
90
Abbott Laboratories plasma vl >3 logs
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Plasma Vl >3 Logs, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasma vl >3 logs/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
plasma vl >3 logs - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vl3-3m2 cell line  (Inserm Transfert)
90
Inserm Transfert vl3-3m2 cell line
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Vl3 3m2 Cell Line, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vl3-3m2 cell line/product/Inserm Transfert
Average 90 stars, based on 1 article reviews
vl3-3m2 cell line - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vl3-3m2 murine thymocyte line  (Cellgro)
90
Cellgro vl3-3m2 murine thymocyte line
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Vl3 3m2 Murine Thymocyte Line, supplied by Cellgro, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vl3-3m2 murine thymocyte line/product/Cellgro
Average 90 stars, based on 1 article reviews
vl3-3m2 murine thymocyte line - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vl-3-1  (TSUMURA)
90
TSUMURA vl-3-1
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Vl 3 1, supplied by TSUMURA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vl-3-1/product/TSUMURA
Average 90 stars, based on 1 article reviews
vl-3-1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
chromas program (vl.3)  (Technelysium ltd)
90
Technelysium ltd chromas program (vl.3)
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Chromas Program (Vl.3), supplied by Technelysium ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chromas program (vl.3)/product/Technelysium ltd
Average 90 stars, based on 1 article reviews
chromas program (vl.3) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
vl3  (LakePharma)
90
LakePharma vl3
Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: <t>6Fr</t> <t>VL3.5</t> guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.
Vl3, supplied by LakePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vl3/product/LakePharma
Average 90 stars, based on 1 article reviews
vl3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: 6Fr VL3.5 guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.

Journal: Journal of Cardiology Cases

Article Title: Ostial left circumflex lesion with calcified nodule successfully treated with excimer laser coronary atherectomy and drug-coated balloon

doi: 10.1016/j.jccase.2020.04.004

Figure Lengend Snippet: Coronary angiography. (A) An angiogram at the baseline showed significant stenosis with a CN at the ostial LCX. (B) The systems are shown. Guide catheter: 6Fr VL3.5 guide catheter (Boston Scientific, Natick, MA, USA); LCX: a 0.014-in. guidewire (Sion Blue; Asahi Intec., Nagoya, Japan); LAD: a 0.014-in. guidewire (Runthrough NS; Terumo, Tokyo, Japan). (C) The balloon dilatation of a 1.75 mm × 15 mm PTCA catheter (canPass; Japan Lifeline Co., Tokyo, Japan). (D) A 0.9 mm concentric catheter of excimer laser coronary atherectomy. (E) A 1.4 mm concentric catheter of excimer laser coronary atherectomy. (F) The dilatation of a 2.5 mm × 13 mm scoring balloon catheter (Lacrosse NSE alpha; Goodman Co., Ltd., Nagoya, Japan). (G) The dilatation of 2.5 mm × 15 mm paclitaxel courted balloon catheter (Sequent Please; B Braun, Melsungen, Germany). (H) Final CAG at the PCI. (I) Follow-up CAG performed 3 months after the PCI. Restenosis at LCX was not identified without coronary flow limitation. (J) Follow-up CAG performed 3 years after the PCI. Restenosis at LCX was not identified without coronary flow limitation.

Article Snippet: The left coronary artery was engaged by a 6Fr VL3.5 guide catheter (Boston Scientific, Natick, MA, US) from a right radial artery approach ( B).

Techniques: